Clinical Trial Update: Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing ipamorelin to placebo reports safety and efficacy data for recovery of gastrointestinal function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Dysmotility

Drugs mentioned

• Ipamorelin (ipamorelin)

Snippet

Sponsor: Helsinn Therapeutics (U.S.), Inc | Conditions: Gastrointestinal Dysmotility | Phase 2 | Status: COMPLETED